跳至主要内容
临床试验/DRKS00018992
DRKS00018992招募中不适用

Determination of microRNA biomarkers from blood for the pre- and post-treatment monitoring of non-small cell lung cancer (NSCLC) - LuMiR-Studie

Hummingbird Diagnostics GmbH0 个研究点目标入组 160 人开始时间: 2019年11月27日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
160

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
50 Years 至 80 Years(—)
性别
All

入选标准

  • Male or female patient 50-80 years
  • Patients suspicious to lung carcinoma (NSCLC) stage I and II or patients by whome the malignancy was excluded after resection (control group 2, for example benign lung disease) or patients with a lung disease (control group 3, eg COPD patients)
  • Sufficient knowledge of German and the willingness to participate in the study

排除标准

  • known active infectious diseases (HIV, HCV, HBV)
  • Neoadjuvant therapy or invasive diagnostics
  • cancer in the last 5 years (except locally treated skin carcinoma - not malignant melanoma or prostate cancer)

研究者

相似试验